SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5457)1/31/1998 4:50:00 PM
From: Robert K.  Respond to of 17367
 
Interesting and relevent article..................................
wwilkins.com
65k total, go down about 70% to article on bacterial translocation
in hemmoraghic shock. Note the comments on sepsis,multiorgan failure
and the conclusion. Remember bpi actions. Good move xoma.



To: aknahow who wrote (5457)1/31/1998 4:52:00 PM
From: Starlight  Respond to of 17367
 
George - Here's another bit of information from Murphy for you to "chew on": He says that in 3-6 mos., XOMA will announce a corporate partner in the trauma trials. He says they have several good candidates, and he expects an announcement by summer.

Betty


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News